Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia
- PMID: 34697797
- PMCID: PMC9034764
- DOI: 10.1111/bjh.17906
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia
Abstract
We report a comparative analysis of patients with therapy-related acute lymphoblastic leukaemia (tr-ALL) vs de novo ALL. We identified 331 patients with B-ALL; 69 (21%) were classified as tr-ALL. The most common prior malignancies were breast (23·2%) and plasma cell disorders (20·3%). Patients with tr-ALL were older (median 63·2 vs. 46·2 years, P < 0.001), more often female (66·7% vs. 43·5%, P < 0·001), and more likely to have hypodiploid cytogenetics (18·8% vs. 5·0%, P < 0·001). In multivariable analysis, patients with tr-ALL were less likely to achieve complete remission [odds ratio (OR) = 0·16, P < 0·001] and more likely to be minimal residual disease-positive (OR = 4·86, P = 0·01) but had similar OS after diagnosis and allo-haematopoietic cell transplantation.
Keywords: ALL; FISH; leukemia; therapy-related.
© 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no relevant conflicts of interest.
Similar articles
-
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients.Haematologica. 2018 Oct;103(10):1662-1668. doi: 10.3324/haematol.2018.193599. Epub 2018 Jun 14. Haematologica. 2018. PMID: 29903756 Free PMC article. Clinical Trial.
-
Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.Br J Haematol. 2019 Sep;186(5):767-776. doi: 10.1111/bjh.15973. Epub 2019 May 22. Br J Haematol. 2019. PMID: 31115916
-
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.Br J Haematol. 2014 Sep;166(5):749-57. doi: 10.1111/bjh.12970. Epub 2014 Jun 25. Br J Haematol. 2014. PMID: 24961645
-
Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission.Br J Haematol. 2013 Apr;161(1):27-42. doi: 10.1111/bjh.12239. Epub 2013 Feb 6. Br J Haematol. 2013. PMID: 23384118 Review.
-
Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis.Ann Hematol. 2020 Nov;99(11):2619-2628. doi: 10.1007/s00277-020-04258-1. Epub 2020 Sep 22. Ann Hematol. 2020. PMID: 32960314
Cited by
-
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry.Bone Marrow Transplant. 2024 Mar;59(3):387-394. doi: 10.1038/s41409-023-02192-0. Epub 2024 Jan 9. Bone Marrow Transplant. 2024. PMID: 38195982
-
Therapy-related B-lymphoblastic leukemia after multiple myeloma.Leuk Res Rep. 2022 Nov 1;18:100358. doi: 10.1016/j.lrr.2022.100358. eCollection 2022. Leuk Res Rep. 2022. PMID: 36353199 Free PMC article.
-
Survival outcomes in secondary and primary acute lymphoblastic leukemia: a systematic review and meta-analysis.Sci Rep. 2025 Jun 2;15(1):19282. doi: 10.1038/s41598-025-95356-5. Sci Rep. 2025. PMID: 40456857 Free PMC article.
-
Therapy-related Acute Lymphoblastic Leukaemia has a Unique Genetic Profile Compared to De Novo Acute Lymphoblastic Leukaemia.J Cancer. 2022 Sep 11;13(12):3326-3332. doi: 10.7150/jca.76719. eCollection 2022. J Cancer. 2022. PMID: 36186901 Free PMC article.
-
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.Blood Cancer J. 2022 Jun 1;12(6):87. doi: 10.1038/s41408-022-00680-y. Blood Cancer J. 2022. PMID: 35650175 Free PMC article. No abstract available.
References
-
- Aldoss I, Dagis A, Palmer J, Forman S, Pullarkat V. Therapy‐related ALL: cytogenetic features and hematopoietic cell transplantation outcome. Bone Marrow Transplant. 2015;50(5):746–8. - PubMed
-
- Kelleher N, Gallardo D, González‐Campos J, Hernández‐Rivas JM, Montesinos P, Sarrá J, et al. Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy. Leukemia & Lymphoma. 2016;57(1):86–91. - PubMed
-
- Aldoss I, Stiller T, Tsai N‐C, Song JY, Cao T, Bandara NA, et al. Therapy‐related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients. Haematologica. 2018;103(10):1662–8. 10.3324/haematol.2018.193599 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources